Research Article
Year 2018,
Volume: 8 Issue: 3, 525 - 530, 30.09.2018
Abstract
Giriş:
Migren
oldukça sık görülen bir baş ağrısı formu olup, kronik migren ya da kronik
gerilim baş ağrısı sonrası ilaç aşırı kullanım baş ağrısı (İAKBA) gelişebilir.
Her iki baş ağrısı formunda da psikiyatrik hastalıklar eşlik edebilir. Bu
çalışmadaki amacımız migren ve İAKBA arasında depresyon,anksiyete ve aleksitimi
bakımından fark olup olmadığını araştırmaktır.
Materyal
ve Method: 25 migren
ve 20 İAKBA tanılı hastalara Beck Depresyon ölçeği, Hamilton Anksiyete
Değerlendirme Ölçeği ve Toronto Aleksitimi Skalası yapılarak değerler
istatistiksel olarak karşılaştırıldı.
Bulgular: Migren
grubunda depresyon ve anksiyete değerleri İAKBA grubuna göre daha yüksek
bulundu (p<0.05). İAKBA grubunda aleksitimik özellik migren grubuna göre
daha yüksek bulundu (p<0.05).
Sonuç:
Depresyon
ve anksiyete seviyesi migren hastalarında daha ön planda iken aleksitimik
kişilik özelliği İAKBA grubunda daha yüksek bulunmuş olup bu durum İAKBA için
öngörülebilir bir faktör olarak da değerlendirilebilir.
References
- 1. Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2013;386: 743–800.2. Muftuoglu MN, Herken H, Demirci H, Virit O, Neyal A. Alexithymic features in migraine patients. Eur Arch Psychiatry Clin Neurosci. 2004;254:182–186.3. Yalug I, Selekler M, Erdogan A, Kutlu A, Dundar G, Ankarali H, et al. Correlations between alexithymia and pain severity, depression, and anxiety among patients with chronic and episodic migraine. Psychiatry Clin Neurosci. 2010;64:231–238.4. Taylor GJ. Recent developments in alexithymia theory and research. Can J Psychiatry. 2000;45:134–142.5. Salminen JK, Saarijarvi S, Toikka T, Kauhanen J, Aarela E. Alexithymia behaves as a personality trait over a 5-year period in Finnish general population. J Psychosom Res. 2006; 61:275–278.6. International headache society; The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.7. Hisli N. Reliability and validity of Beck depression inventory among university students [in Turkish]. Psikoloji Dergisi. 1989;7:3–13.8. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.9. Bagby RM, Taylor GJ, Parker JDA. The Twenty-item Toronto Alexithymia Scale-II convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38:33–40.10. Kose S, Sayar K, Gulec H, Evren C, Borckardt J. The Turkish version of the 20-Item Toronto Alexithymia Scale (TAS20): reliability, validity, and factorial structure. Society of Biological Psychiatry Symposium. 2005; May 19–22, Atlanta, GA.11. Sifneos PE. The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother Psychosom. 1973;22:255–262.12. Grabe HJ, Spitzer C, Freyberger HJ. Alexythymia and personality in relation to dimensions of psychopathology. Am J Psychiatry.2004;161:1299–1301.13. Lumley MA, Smith JA, Longo DJ. The relationship of alexithymia to pain severity and impairment among patients with chronic myofascial pain: comparisons with self-efficacy, catastrophizing, and depression. J Psychosom Re. 2002;53:823–830 25.14. Wise TN, Mann LS, Jani N, Jani S. Illness beliefs and alexithymia in headache patients. Headache. 1994;34:362–365.15. Lumley MA, Radcliffe AM, Macklem DJ, Mosley-Williams A, Leisen JC, Huffman JL, et al. Alexithymia and pain in three chronic pain samples: comparing Caucasians and African Americans. Pain Med. 2005;6:251–261.16. Dikmen PY, Aysevener EO, Kosak S, Aydınlar EI, Kocaman AS. Relationship between MIDAS, depression, anxiety and alexithymia in migraine patients. Acta Neurologica Belgica. 2017;1-8.17. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain. 2012;153:56–61.18. Munksgaard SB, Jensen RH. Medication overuse headache. Headache. 2014;54:1251–7.19. Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31:837–50.20. Bottiroli S, Galli F, Viana M, Sances G, Allena M, Ghiotto N et al. Alexithymia and chronic migraine with medication overuse: what relationship?. The Journal of Headache and Pain. 2015. 16 (Suppl 1):A150.
Year 2018,
Volume: 8 Issue: 3, 525 - 530, 30.09.2018
Abstract
References
- 1. Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2013;386: 743–800.2. Muftuoglu MN, Herken H, Demirci H, Virit O, Neyal A. Alexithymic features in migraine patients. Eur Arch Psychiatry Clin Neurosci. 2004;254:182–186.3. Yalug I, Selekler M, Erdogan A, Kutlu A, Dundar G, Ankarali H, et al. Correlations between alexithymia and pain severity, depression, and anxiety among patients with chronic and episodic migraine. Psychiatry Clin Neurosci. 2010;64:231–238.4. Taylor GJ. Recent developments in alexithymia theory and research. Can J Psychiatry. 2000;45:134–142.5. Salminen JK, Saarijarvi S, Toikka T, Kauhanen J, Aarela E. Alexithymia behaves as a personality trait over a 5-year period in Finnish general population. J Psychosom Res. 2006; 61:275–278.6. International headache society; The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.7. Hisli N. Reliability and validity of Beck depression inventory among university students [in Turkish]. Psikoloji Dergisi. 1989;7:3–13.8. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.9. Bagby RM, Taylor GJ, Parker JDA. The Twenty-item Toronto Alexithymia Scale-II convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38:33–40.10. Kose S, Sayar K, Gulec H, Evren C, Borckardt J. The Turkish version of the 20-Item Toronto Alexithymia Scale (TAS20): reliability, validity, and factorial structure. Society of Biological Psychiatry Symposium. 2005; May 19–22, Atlanta, GA.11. Sifneos PE. The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother Psychosom. 1973;22:255–262.12. Grabe HJ, Spitzer C, Freyberger HJ. Alexythymia and personality in relation to dimensions of psychopathology. Am J Psychiatry.2004;161:1299–1301.13. Lumley MA, Smith JA, Longo DJ. The relationship of alexithymia to pain severity and impairment among patients with chronic myofascial pain: comparisons with self-efficacy, catastrophizing, and depression. J Psychosom Re. 2002;53:823–830 25.14. Wise TN, Mann LS, Jani N, Jani S. Illness beliefs and alexithymia in headache patients. Headache. 1994;34:362–365.15. Lumley MA, Radcliffe AM, Macklem DJ, Mosley-Williams A, Leisen JC, Huffman JL, et al. Alexithymia and pain in three chronic pain samples: comparing Caucasians and African Americans. Pain Med. 2005;6:251–261.16. Dikmen PY, Aysevener EO, Kosak S, Aydınlar EI, Kocaman AS. Relationship between MIDAS, depression, anxiety and alexithymia in migraine patients. Acta Neurologica Belgica. 2017;1-8.17. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain. 2012;153:56–61.18. Munksgaard SB, Jensen RH. Medication overuse headache. Headache. 2014;54:1251–7.19. Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31:837–50.20. Bottiroli S, Galli F, Viana M, Sances G, Allena M, Ghiotto N et al. Alexithymia and chronic migraine with medication overuse: what relationship?. The Journal of Headache and Pain. 2015. 16 (Suppl 1):A150.
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Articles |
| Authors | |
| Publication Date | September 30, 2018 |
| Submission Date | July 11, 2018 |
| Published in Issue | Year 2018 Volume: 8 Issue: 3 |
The published articles in SMJ are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.